Bristol-Myers Squibb's Earnings Made Easy

Midsummer is considered prime beach season, but investors know that, more importantly, it's second-quarter earnings season.

With that in mind, this episode of The Motley Fool's Market Checkup is dedicated to heavy hitters in the pharmaceutical industry. Watch and find out how the second-quarter results of four Big Pharma stocks stack up, and what challenges and opportunities lie ahead for them.

In this video, health-care analysts David Williamson and Max Macaluso drill down on Bristol-Myers Squibb's recent results, detailing everything investors need to know, including what key drugs could propel the stock higher.

Still in the dark about how Obamacare might affect you and your portfolio? Don't worry -- you're not alone. To help prepare investors for the massive changes coming to the American health0care system, The Motley Fool created a special free report that makes this complex topic easily understandable. Download "Everything You Need to Know About Obamacare" and discover how the law may affect your taxes, health insurance, and investments. Click here for your free copy today.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2589846, ~/Articles/ArticleHandler.aspx, 4/17/2014 5:36:20 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement